Determinants of seeding and spreading of α-synuclein pathology in the brain.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
11 2020
Historique:
received: 16 04 2020
accepted: 22 09 2020
entrez: 12 11 2020
pubmed: 13 11 2020
medline: 15 4 2022
Statut: epublish

Résumé

In Parkinson's disease (PD), fibrillar forms of α-synuclein are hypothesized to propagate through synaptically coupled networks, causing Lewy pathology (LP) and neurodegeneration. To more rigorously characterize the determinants of spreading, preformed α-synuclein fibrils were injected into the mouse pedunculopontine nucleus (PPN), a brain region that manifests LP in PD patients and the distribution of developing α-synuclein pathology compared to that ascertained by anterograde and retrograde connectomic mapping. Within the PPN, α-synuclein pathology was cell-specific, being robust in PD-vulnerable cholinergic neurons but not in neighboring noncholinergic neurons. While nearly all neurons projecting to PPN cholinergics manifested α-synuclein pathology, the kinetics, magnitude, and persistence of the propagated pathology were unrelated to the strength of those connections. Thus, neuronal phenotype governs the somatodendritic uptake of pathological α-synuclein, and while the afferent connectome restricts the subsequent spreading of pathology, its magnitude and persistence is not a strict function of the strength of coupling.

Identifiants

pubmed: 33177086
pii: 6/46/eabc2487
doi: 10.1126/sciadv.abc2487
pmc: PMC7673735
pii:
doi:

Substances chimiques

alpha-Synuclein 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIA NIH HHS
ID : K01 AG056841
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS107318
Pays : United States

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Références

Acta Neuropathol. 2018 Jan;135(1):65-83
pubmed: 29209768
Eur J Neurosci. 2012 Mar;35(5):723-34
pubmed: 22356461
Acta Neuropathol Commun. 2018 May 10;6(1):39
pubmed: 29747690
Acta Neuropathol. 2009 Jun;117(6):613-34
pubmed: 19399512
J Biol Chem. 2006 Oct 6;281(40):29739-52
pubmed: 16847063
Nat Cell Biol. 2002 Feb;4(2):160-4
pubmed: 11813001
Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4971-4982
pubmed: 32075919
Brain. 2019 Nov 1;142(11):3565-3579
pubmed: 31580415
J Neurosci. 2017 Feb 1;37(5):1352-1366
pubmed: 28039375
Nature. 2018 Jan 25;553(7689):455-460
pubmed: 29342142
Am J Pathol. 2013 Dec;183(6):1826-1840
pubmed: 24099985
Nat Commun. 2018 Feb 19;9(1):712
pubmed: 29459792
Science. 2018 Nov 2;362(6414):
pubmed: 30385548
Parkinsonism Relat Disord. 2008 Nov;14(7):553-7
pubmed: 18329941
Cold Spring Harb Perspect Med. 2018 Mar 1;8(3):
pubmed: 28108534
J Exp Med. 2016 Aug 22;213(9):1759-78
pubmed: 27503075
Neuroscience. 1997 Jun;78(3):771-94
pubmed: 9153657
Neurobiol Dis. 2020 Feb;134:104623
pubmed: 31628991
Nat Rev Neurosci. 2017 Jan 20;18(2):101-113
pubmed: 28104909
Science. 2012 Nov 16;338(6109):949-53
pubmed: 23161999
Mol Neurodegener. 2018 Feb 22;13(1):9
pubmed: 29467003
Ann Neurol. 2014 Mar;75(3):351-62
pubmed: 24243558
Science. 2016 Sep 30;353(6307):
pubmed: 27708076
PLoS Biol. 2019 Jun 18;17(6):e3000318
pubmed: 31211781
Nat Commun. 2018 Aug 27;9(1):3465
pubmed: 30150626
Acta Neuropathol. 2014 Dec;128(6):805-20
pubmed: 25296989
J Clin Invest. 2010 Aug;120(8):2745-54
pubmed: 20628197
Nature. 1997 Aug 28;388(6645):839-40
pubmed: 9278044
Neuron. 2019 Aug 21;103(4):627-641.e7
pubmed: 31255487
J Neurol Neurosurg Psychiatry. 1988 Apr;51(4):540-3
pubmed: 3379428
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
pubmed: 12498954
Curr Biol. 2015 Sep 21;25(18):2349-60
pubmed: 26320949
Brain. 1991 Oct;114 ( Pt 5):2253-67
pubmed: 1718530
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Acta Neuropathol Commun. 2018 Sep 19;6(1):96
pubmed: 30231908
EMBO J. 2015 Oct 1;34(19):2408-23
pubmed: 26323479
J Physiol. 2008 Jun 15;586(12):2947-60
pubmed: 18440991
J Neural Transm (Vienna). 2019 Apr;126(4):377-396
pubmed: 30643975
Science. 2015 Aug 7;349(6248):1255555
pubmed: 26250687
J Neurochem. 2015 Oct;135(1):4-18
pubmed: 26134497
Proc Natl Acad Sci U S A. 1987 Aug;84(16):5976-80
pubmed: 3475716
J Neurosci. 2015 Apr 1;35(13):5221-32
pubmed: 25834048
Mol Neurodegener. 2019 Aug 16;14(1):34
pubmed: 31419995
Neurobiol Aging. 2019 Nov;83:11-20
pubmed: 31585362
Front Neurol. 2018 Jun 19;9:455
pubmed: 29971039
Neuropathol Appl Neurobiol. 2007 Dec;33(6):599-614
pubmed: 17961138
Nature. 2015 Jun 18;522(7556):340-4
pubmed: 26061766
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):E5308-17
pubmed: 26324905
Nat Neurosci. 2019 Jul;22(7):1099-1109
pubmed: 31235907
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):E3138-47
pubmed: 23898162
J Clin Invest. 2019 Jun 13;129(9):3738-3753
pubmed: 31194700
J Neurosci Methods. 2010 Dec 15;194(1):2-20
pubmed: 20004688
Cell. 2016 Jan 28;164(3):526-37
pubmed: 26824660
Neurobiol Dis. 2019 Aug;128:3-8
pubmed: 30171892
Acta Neuropathol. 2013 Oct;126(4):555-73
pubmed: 23925565
Nat Rev Mol Cell Biol. 2003 Jul;4(7):517-29
pubmed: 12838335
Neuron. 2017 Apr 5;94(1):7-18
pubmed: 28384477
Nat Commun. 2019 Dec 4;10(1):5535
pubmed: 31797870
Ann Neurol. 2012 Oct;72(4):517-24
pubmed: 23109146
J Neurochem. 2019 Sep;150(5):577-590
pubmed: 31069800
Nat Med. 2008 May;14(5):504-6
pubmed: 18391962
Neuroreport. 2001 Jul 20;12(10):2085-90
pubmed: 11447312
Nat Neurosci. 2019 Aug;22(8):1248-1257
pubmed: 31346295
Nature. 2015 Aug 6;524(7563):88-92
pubmed: 26131933
Acta Neuropathol. 2013 Dec;126(6):793-807
pubmed: 23912309
Nature. 2014 Apr 10;508(7495):207-14
pubmed: 24695228
Nat Protoc. 2013 Aug;8(8):1583-601
pubmed: 23887178
Cell Rep. 2015 Mar 3;10(8):1252-60
pubmed: 25732816
Brain. 2013 Apr;136(Pt 4):1128-38
pubmed: 23466394
J Neurosci. 2017 Oct 11;37(41):9799-9807
pubmed: 29021297
J Comp Neurol. 2011 Dec 1;519(17):3402-14
pubmed: 21618237
Mol Cell Neurosci. 2013 May;54:71-83
pubmed: 23369945
Front Neuroanat. 2018 May 11;12:34
pubmed: 29867374
Neuron. 2007 Mar 1;53(5):639-47
pubmed: 17329205
Neuron. 2016 May 18;90(4):675-91
pubmed: 27196972
J Comp Neurol. 2009 Aug 1;515(4):397-408
pubmed: 19459217
J Neurosci. 2013 Jul 17;33(29):11986-93
pubmed: 23864685
Cell. 2015 Jul 30;162(3):622-34
pubmed: 26232228
Neuron. 2011 Oct 6;72(1):57-71
pubmed: 21982369

Auteurs

Martin T Henrich (MT)

Department of Physiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Department of Neurology, Philipps University Marburg, Marburg 35043, Germany.

Fanni F Geibl (FF)

Department of Neurology, Philipps University Marburg, Marburg 35043, Germany.

Harini Lakshminarasimhan (H)

Department of Physiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

Anna Stegmann (A)

Department of Neurology, Philipps University Marburg, Marburg 35043, Germany.

Benoit I Giasson (BI)

Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USA.

Xiaobo Mao (X)

Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Valina L Dawson (VL)

Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Ted M Dawson (TM)

Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.

Wolfgang H Oertel (WH)

Department of Neurology, Philipps University Marburg, Marburg 35043, Germany.

D James Surmeier (DJ)

Department of Physiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. j-surmeier@northwestern.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH